ALPS Advisors’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

ALPS Advisors’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-22,929	Closed	-$824K	–	1163
2022 Q4	$824K	Buy	22,929 +4,556	+25%	+$114K	0.01%	518
2022 Q3	$277K	Sell	18,373 -1,640	-8%	-$26.6K	﹤0.01%	923
2022 Q2	$268K	Sell	20,013 -14,447	-42%	-$229K	﹤0.01%	905
2022 Q1	$664K	Sell	34,460 -4,342	-11%	-$90.1K	0.01%	375
2021 Q4	$920K	Buy	+38,802	New	+$899K	0.01%	371

ALPS Advisors's IMGO Position: Q1 2023 in Review

ALPS Advisors sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 22,929 shares — an estimated $824K sold.

ALPS Advisors first reported a position in IMGO in Q4 2021 and held it in 5 quarters. The position peaked at $920K in Q4 2021. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

ALPS Advisors reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
ALPS Advisors sold 22,929 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $824K.
ALPS Advisors first reported a position in Imago BioSciences, Inc. Common stock in Q4 2021 and held it in 5 quarters.
ALPS Advisors's Imago BioSciences, Inc. Common stock position peaked at $920K in Q4 2021.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on ALPS Advisors's 13F filing for Q1 2023, filed 10 May 2023.